What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
EMA CHMP Recommends 12 Medicines for Approval
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended 12 new medicines for approval and six for extension of therapeutic indications. This includes novel treatments for influenza, COVID-19, paediatric brain tumours, Parkinson's disease, and several biosimilar medicines.
EMA Recommends Ojemda for Paediatric Low-Grade Glioma
The European Medicines Agency (EMA) has recommended a conditional marketing authorisation for Ojemda (tovorafenib) to treat paediatric low-grade glioma in patients aged 6 months and older with specific BRAF gene alterations. This recommendation addresses an unmet medical need for a targeted therapy in this patient population.
California Officials Seize Illegal Cannabis Plants Worth $57 Million
California state officials, led by Governor Gavin Newsom, announced the seizure of over 58,000 illegal cannabis plants and approximately three tons of processed cannabis in November. The operation, conducted by the Department of Cannabis Control, targeted the illicit market and resulted in the eradication of plants and product valued at an estimated $56.5 million.
Cannabis Business Dispute and Fraud Avoidance Guidance
The California Department of Cannabis Control (DCC) has issued guidance on avoiding business disputes and fraud within the cannabis industry. The document outlines proactive measures for vetting partners, understanding contracts, and maintaining records to prevent common pitfalls.
DCC Awards $30 Million in Cannabis Research Grants
The California Department of Cannabis Control (DCC) awarded nearly $30 million in research grants to nine academic institutions for 22 projects. This funding, derived from cannabis tax revenues, supports research on economic dynamics, public health, and environmental impacts related to cannabis.
Sonoma County CEQA Cannabis Projects Public Comment
The California Department of Cannabis Control (DCC) has released draft environmental documents for three commercial cannabis projects in Sonoma County for public review and comment. These documents, prepared under the California Environmental Quality Act (CEQA), analyze potential environmental impacts and propose mitigation measures. The comment period is open until March 1, 2026.
California Seizes Over $1.2 Billion in Illegal Cannabis
California announced state officers have seized and destroyed over $1.2 billion in illicit cannabis products through the Unified Cannabis Enforcement Task Force (UCETF). Seizures in 2025 alone reached $609 million, an 18-fold increase since 2022, highlighting the state's efforts to combat the illegal market.
I&S LLC Stipulation, Agreement, and Order
The Federal Trade Commission (FTC) has entered into a Stipulation, Agreement, and Order with I&S LLC. The order addresses alleged deceptive advertising practices related to the company's subscription services. I&S LLC has agreed to specific terms to resolve these allegations.
Dutch Botanicals LLC Stipulation Agreement Order
The US Food and Drug Administration (FDA) has issued a Stipulation Agreement Order against Dutch Botanicals LLC. This order likely addresses violations related to the manufacturing or marketing of food products, requiring specific actions and potentially imposing penalties.
Galactic Meds LLC Stipulation, Agreement, and Order
The US Department of Justice has entered into a Stipulation, Agreement, and Order with Galactic Meds LLC. This agreement resolves alleged violations related to the False Claims Act, requiring Galactic Meds LLC to pay a settlement amount and implement compliance measures.
Browse by country
United States
1815 sources
United Kingdom
90 sources
European Union
77 sources
Canada
39 sources
International
39 sources
Australia
22 sources
Singapore
21 sources
India
13 sources
France
13 sources
Japan
10 sources
Italy
8 sources
Hong Kong
7 sources
Switzerland
6 sources
Ireland
6 sources
Germany
6 sources
Poland
5 sources
MT
5 sources
UAE
4 sources
New Zealand
4 sources
Luxembourg
4 sources
South Africa
3 sources
NG
3 sources
South Korea
3 sources
GH
3 sources
CL
2 sources
GG
2 sources
GI
2 sources
SA
2 sources
Austria
2 sources
KY
2 sources
CY
2 sources
KE
2 sources
Norway
2 sources
Netherlands
2 sources
IL
1 sources
Greece
1 sources
INT
1 sources
LK
1 sources
SE
1 sources
Hungary
1 sources
Romania
1 sources
Uganda
1 sources
Spain
1 sources
Croatia
1 sources
CO
1 sources
Finland
1 sources
BM
1 sources
MU
1 sources
QA
1 sources
DK
1 sources
Browse by category
Courts & Legal
362 sources
Banking & Finance
292 sources
Government & Legislation
280 sources
Trade & Sanctions
136 sources
Healthcare
136 sources
Labor & Employment
113 sources
Securities & Markets
104 sources
Pharma & Drug Safety
104 sources
Energy
101 sources
Environment
86 sources
Data Privacy & Cybersecurity
74 sources
Tax
66 sources
Agriculture & Food Safety
64 sources
Insurance
58 sources
Transportation
57 sources
Defense & National Security
52 sources
Telecom & Technology
47 sources
Consumer Protection
44 sources
Education
19 sources
Housing
16 sources
Securities Regulation
9 sources
Environmental Regulation
8 sources
Immigration
8 sources
Public Health
3 sources
AI Regulation
3 sources
Financial Regulation
2 sources
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.